-
1
-
-
42349087252
-
Microvascular and macrovascular complications of diabetes
-
DOI 10.2337/diaclin.26.2.77
-
MJ Fowler 2008 Microvascular and macrovascular complications of diabetes Clin Diab 26 77 82 10.2337/diaclin.26.2.77 10.2337/diaclin.26.2.77 (Pubitemid 351556223)
-
(2008)
Clinical Diabetes
, vol.26
, Issue.2
, pp. 77-82
-
-
Fowler, M.J.1
-
2
-
-
0032815449
-
Molecular mechanisms of diabetic renal hypertrophy
-
DOI 10.1046/j.1523-1755.1999.00590.x
-
G Wolf FN Ziyadeh 1999 Molecular mechanisms of diabetic renal hypertrophy Kidney Int 56 393 405 10.1046/j.1523-1755.1999.00590.x 10.1046/j.1523-1755. 1999.00590.x 10432377 1:CAS:528:DyaK1MXltlOhurs%3D (Pubitemid 29353136)
-
(1999)
Kidney International
, vol.56
, Issue.2
, pp. 393-405
-
-
Wolf, G.1
Ziyadeh, F.N.2
-
3
-
-
0033864452
-
Cell cycle regulation in diabetic nephropathy
-
10.1046/j.1523-1755.2000.07710.x 10.1046/j.1523-1755.2000.07710.x 1:CAS:528:DC%2BD3cXms1Oiu74%3D
-
G Wolf 2000 Cell cycle regulation in diabetic nephropathy Kidney Int 77 S59 S66 10.1046/j.1523-1755.2000.07710.x 10.1046/j.1523-1755.2000.07710.x 1:CAS:528:DC%2BD3cXms1Oiu74%3D
-
(2000)
Kidney Int
, vol.77
-
-
Wolf, G.1
-
4
-
-
34250361947
-
Cellular and molecular mechanisms of proteinuria in diabetic nephropathy
-
DOI 10.1159/000101797
-
G Wolf FN Ziyadeh 2007 Cellular and molecular mechanisms of proteinuria in diabetic nephropathy Nephron Physiol 106 26 31 10.1159/000101797 10.1159/000101797 1:CAS:528:DC%2BD2sXmsVOis7w%3D (Pubitemid 46920097)
-
(2007)
Nephron - Physiology
, vol.106
, Issue.2
-
-
Wolf, G.1
Ziyadeh, F.N.2
-
5
-
-
0042329877
-
Mast cell infiltration and chemokine expression in progressive renal disease
-
DOI 10.1046/j.1523-1755.2003.00183.x
-
SE Jones DJ Kelly AJ Cox, et al. 2003 Mast cell infiltration and chemokine expression in progressive renal disease Kidney Int 64 906 913 10.1046/j.1523-1755.2003.00183.x 10.1046/j.1523-1755.2003.00183.x 12911540 1:CAS:528:DC%2BD3sXntl2mtbY%3D (Pubitemid 37013826)
-
(2003)
Kidney International
, vol.64
, Issue.3
, pp. 906-913
-
-
Jones, S.E.1
Kelly, D.J.2
Cox, A.J.3
Zhang, Y.4
Gow, R.M.5
Gilbert, R.E.6
-
6
-
-
33947407995
-
Different approaches to study mast cell functions
-
DOI 10.1016/j.intimp.2007.01.009, PII S1567576907000276
-
R Sur D Cavender R Malaviya 2007 Different approaches to study mast cell functions Int Immunopharmacol 7 555 567 10.1016/j.intimp.2007.01.009 10.1016/j.intimp.2007.01.009 17386403 1:CAS:528:DC%2BD2sXjsVSqtLc%3D (Pubitemid 46453277)
-
(2007)
International Immunopharmacology
, vol.7
, Issue.5
, pp. 555-567
-
-
Sur, R.1
Cavender, D.2
Malaviya, R.3
-
7
-
-
0034958845
-
Mast cells find their way to the kidney
-
DOI 10.1046/j.1523-1755.2001.00811.x
-
AA Eddy 2001 Mast cells find their way to the kidney Kidney Int 60 375 377 10.1046/j.1523-1755.2001.00811.x 10.1046/j.1523-1755.2001.00811.x 11422775 1:STN:280:DC%2BD3Mzmt1yjug%3D%3D (Pubitemid 32587578)
-
(2001)
Kidney International
, vol.60
, Issue.1
, pp. 375-377
-
-
Eddy, A.A.1
-
8
-
-
0033773726
-
Mast cells: The forgotten cells of renal fibrosis
-
DOI 10.1136/jcp.53.11.858
-
IS Roberts PE Brenchley 2000 Mast cells: the forgotten cells of renal fibrosis J Clin Pathol 53 858 862 10.1136/jcp.53.11.858 10.1136/jcp.53.11.858 11127270 1:STN:280:DC%2BD3M7gsVaisw%3D%3D (Pubitemid 30836768)
-
(2000)
Journal of Clinical Pathology
, vol.53
, Issue.11
, pp. 858-862
-
-
Roberts, I.S.D.1
Brenchley, P.E.C.2
-
9
-
-
37349054092
-
Resident cardiac mast cells: Are they the major culprit in the pathogenesis of cardiac hypertrophy?
-
17973902 1:CAS:528:DC%2BD1cXhs1Cqt7k%3D
-
P Balakumar AP Singh SS Ganti, et al. 2008 Resident cardiac mast cells: are they the major culprit in the pathogenesis of cardiac hypertrophy? Basic Clin Pharmacol Toxicol 102 5 9 17973902 1:CAS:528:DC%2BD1cXhs1Cqt7k%3D
-
(2008)
Basic Clin Pharmacol Toxicol
, vol.102
, pp. 5-9
-
-
Balakumar, P.1
Singh, A.P.2
Ganti, S.S.3
-
10
-
-
53249144566
-
Effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats
-
10.1097/FJC.0b013e31817ae60f 10.1097/FJC.0b013e31817ae60f 18520950 1:CAS:528:DC%2BD1cXnslaksbc%3D
-
AP Singh M Singh P Balakumar 2008 Effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats J Cardiovasc Pharmacol 51 596 604 10.1097/FJC.0b013e31817ae60f 10.1097/FJC.0b013e31817ae60f 18520950 1:CAS:528:DC%2BD1cXnslaksbc%3D
-
(2008)
J Cardiovasc Pharmacol
, vol.51
, pp. 596-604
-
-
Singh, A.P.1
Singh, M.2
Balakumar, P.3
-
11
-
-
0024461089
-
Recent advances in the cellular and molecular biology of mast cells
-
10.1016/0167-5699(89)90272-7 10.1016/0167-5699(89)90272-7 2692594 1:CAS:528:DyaK3cXjsVWhsQ%3D%3D
-
RL Stevens KF Austen 1989 Recent advances in the cellular and molecular biology of mast cells Immunol Today 10 381 386 10.1016/0167-5699(89)90272-7 10.1016/0167-5699(89)90272-7 2692594 1:CAS:528:DyaK3cXjsVWhsQ%3D%3D
-
(1989)
Immunol Today
, vol.10
, pp. 381-386
-
-
Stevens, R.L.1
Austen, K.F.2
-
12
-
-
0026522959
-
Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils
-
1588043 1:CAS:528:DyaK38XksVKntbo%3D
-
DG Raible ES Schulman J DiMuzio, et al. 1992 Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils J Immunol 148 3536 3542 1588043 1:CAS:528:DyaK38XksVKntbo%3D
-
(1992)
J Immunol
, vol.148
, pp. 3536-3542
-
-
Raible, D.G.1
Schulman, E.S.2
Dimuzio, J.3
-
13
-
-
4544338137
-
Mast cells: A unique source of renin
-
DOI 10.1073/pnas.0403208101
-
RB Silver AC Reid CJ Mackins, et al. 2004 Mast cells: a unique source of renin Proc Natl Acad Sci USA 101 13607 13612 10.1073/pnas.0403208101 10.1073/pnas.0403208101 15342908 1:CAS:528:DC%2BD2cXnvFehs74%3D (Pubitemid 39238450)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.37
, pp. 13607-13612
-
-
Silver, R.B.1
Reid, A.C.2
Mackins, C.J.3
Askwith, T.4
Schaefer, U.5
Herzlinger, D.6
Levi, R.7
-
14
-
-
33745725939
-
Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves
-
DOI 10.1093/eurheartj/ehi706
-
S Helske S Syvaranta M Kupari, et al. 2006 Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves Eur Heart J 27 1495 1504 10.1093/eurheartj/ehi706 10.1093/eurheartj/ehi706 16401677 1:CAS:528:DC%2BD28Xnt1Giu7s%3D (Pubitemid 43998085)
-
(2006)
European Heart Journal
, vol.27
, Issue.12
, pp. 1495-1504
-
-
Helske, S.1
Syvaranta, S.2
Kupari, M.3
Lappalainen, J.4
Laine, M.5
Lommi, J.6
Turto, H.7
Mayranpaa, M.8
Werkkala, K.9
Kovanen, P.T.10
Lindstedt, K.A.11
-
15
-
-
36349037070
-
Increased mast cell density in renal interstitium is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis
-
18074865
-
K Okon J Stachura 2007 Increased mast cell density in renal interstitium is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis Pol J Pathol 58 193 197 18074865
-
(2007)
Pol J Pathol
, vol.58
, pp. 193-197
-
-
Okon, K.1
Stachura, J.2
-
16
-
-
61349119943
-
Vascular endothelial dysfunction: A tug of war in diabetic nephropathy?
-
10.1016/j.biopha.2008.08.008 10.1016/j.biopha.2008.08.008 18823739 1:CAS:528:DC%2BD1MXisFWgtb8%3D
-
P Balakumar VA Chakkarwar P Kishan, et al. 2009 Vascular endothelial dysfunction: a tug of war in diabetic nephropathy? Biomed Pharmacother 63 171 179 10.1016/j.biopha.2008.08.008 10.1016/j.biopha.2008.08.008 18823739 1:CAS:528:DC%2BD1MXisFWgtb8%3D
-
(2009)
Biomed Pharmacother
, vol.63
, pp. 171-179
-
-
Balakumar, P.1
Chakkarwar, V.A.2
Kishan, P.3
-
17
-
-
0033851637
-
Role of angiotensin II in diabetic nephropathy
-
10.1046/j.1523-1755.2000.07715.x 10.1046/j.1523-1755.2000.07715.x 1:CAS:528:DC%2BD3cXms1Oiu7o%3D
-
DJ Leehey AK Singh N Alavi, et al. 2000 Role of angiotensin II in diabetic nephropathy Kidney Int 77 S93 S98 10.1046/j.1523-1755.2000.07715.x 10.1046/j.1523-1755.2000.07715.x 1:CAS:528:DC%2BD3cXms1Oiu7o%3D
-
(2000)
Kidney Int
, vol.77
-
-
Leehey, D.J.1
Singh, A.K.2
Alavi, N.3
-
18
-
-
0035103048
-
Effects of endothelin receptor antagonists on the progression of diabetic nephropathy
-
DOI 10.1159/000045906
-
B Hocher A Schwarz D Reinbacher, et al. 2001 Effects of endothelin receptor antagonists on the progression of diabetic nephropathy Nephron 87 161 169 10.1159/000045906 10.1159/000045906 11244312 1:CAS:528:DC%2BD3MXit1ensbY%3D (Pubitemid 32215829)
-
(2001)
Nephron
, vol.87
, Issue.2
, pp. 161-169
-
-
Hocher, B.1
Schwarz, A.2
Reinbacher, D.3
Jacobi, J.4
Lun, A.5
Priem, F.6
Bauer, C.7
Neumayer, H.-H.8
Raschack, M.9
-
19
-
-
0036435877
-
Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy
-
10.1046/j.1523-1755.62.s82.3.x 10.1046/j.1523-1755.62.s82.3.x
-
HR Choles BS Kasinath Y Gorin, et al. 2002 Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy Kidney Int 62 S8 S11 10.1046/j.1523-1755.62.s82.3.x 10.1046/j.1523-1755.62.s82.3.x
-
(2002)
Kidney Int
, vol.62
-
-
Choles, H.R.1
Kasinath, B.S.2
Gorin, Y.3
-
20
-
-
0041364626
-
Role of advanced glycation end products in diabetic nephropathy
-
10.1097/01.ASN.0000077413.41276.17 10.1097/01.ASN.0000077413.41276.17 12874442 1:CAS:528:DC%2BD3sXmslCqsLg%3D
-
JM Forbes ME Cooper MD Oldfield, et al. 2003 Role of advanced glycation end products in diabetic nephropathy J Am Soc Nephrol 14 S254 S258 10.1097/01.ASN.0000077413.41276.17 10.1097/01.ASN.0000077413.41276.17 12874442 1:CAS:528:DC%2BD3sXmslCqsLg%3D
-
(2003)
J Am Soc Nephrol
, vol.14
-
-
Forbes, J.M.1
Cooper, M.E.2
Oldfield, M.D.3
-
21
-
-
34249110684
-
Roles of lipid mediators in kidney injury
-
DOI 10.1016/j.semnephrol.2007.02.008, PII S0270929507000393, Mechanisms of Tissue Injury in Acute and Chronic Renal Disease
-
CM Hao MD Breyer 2007 Roles of lipid mediators in kidney injury Semin Nephrol 27 338 351 10.1016/j.semnephrol.2007.02.008 10.1016/j.semnephrol.2007. 02.008 17533010 1:CAS:528:DC%2BD2sXot1ejurg%3D (Pubitemid 46802920)
-
(2007)
Seminars in Nephrology
, vol.27
, Issue.3
, pp. 338-351
-
-
Hao, C.-M.1
Breyer, M.D.2
-
22
-
-
41149157859
-
Increased renal gene transcription of protein kinase C-β in human diabetic nephropathy: Relationship to long-term glycaemic control
-
10.1007/s00125-008-0927-x 10.1007/s00125-008-0927-x 18278479 1:CAS:528:DC%2BD1cXjsFGiu7Y%3D
-
RG Langham DJ Kelly RM Gow, et al. 2008 Increased renal gene transcription of protein kinase C-β in human diabetic nephropathy: relationship to long-term glycaemic control Diabetologia 51 668 674 10.1007/s00125-008-0927-x 10.1007/s00125-008-0927-x 18278479 1:CAS:528:DC%2BD1cXjsFGiu7Y%3D
-
(2008)
Diabetologia
, vol.51
, pp. 668-674
-
-
Langham, R.G.1
Kelly, D.J.2
Gow, R.M.3
-
23
-
-
33751350541
-
The role of TNF-α in diabetic nephropathy: Pathogenic and therapeutic implications
-
DOI 10.1016/j.cytogfr.2006.09.011, PII S1359610106000608
-
JF Navarro C Mora-Fernandez 2006 The role of TNF-α in diabetic nephropathy: pathogenic and therapeutic implications Cytokine Growth Factor Rev 17 441 450 10.1016/j.cytogfr.2006.09.011 10.1016/j.cytogfr.2006.09.011 17113815 1:CAS:528:DC%2BD28Xht1eqtb7P (Pubitemid 44803222)
-
(2006)
Cytokine and Growth Factor Reviews
, vol.17
, Issue.6
, pp. 441-450
-
-
Navarro, J.F.1
Mora-Fernandez, C.2
-
24
-
-
19944396117
-
Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy
-
DOI 10.1053/j.ajkd.2004.08.039, PII S0272638604013083
-
N Sakai T Wada K Furuichi, et al. 2005 Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy Am J Kidney Dis 45 54 65 10.1053/j.ajkd.2004.08.039 10.1053/j.ajkd.2004.08.039 15696444 1:CAS:528:DC%2BD2MXhtVOrtrw%3D (Pubitemid 40038045)
-
(2005)
American Journal of Kidney Diseases
, vol.45
, Issue.1
, pp. 54-65
-
-
Sakai, N.1
Wada, T.2
Furuichi, K.3
Iwata, Y.4
Yoshimoto, K.5
Kitagawa, K.6
Kokubo, S.7
Kobayashi, M.8
Hara, A.9
Yamahana, J.10
Okumura, T.11
Takasawa, K.12
Takeda, S.-I.13
Yoshimura, M.14
Kida, H.15
Yokoyama, H.16
-
25
-
-
48249141108
-
RhoA/Rho-Kinase contribute to the pathogenesis of diabetic renal disease
-
10.2337/db07-1149 10.2337/db07-1149 18356410 1:CAS:528: DC%2BD1cXnsF2is7s%3D
-
F Peng D Wu B Gao, et al. 2008 RhoA/Rho-Kinase contribute to the pathogenesis of diabetic renal disease Diabetes 57 1683 1692 10.2337/db07-1149 10.2337/db07-1149 18356410 1:CAS:528:DC%2BD1cXnsF2is7s%3D
-
(2008)
Diabetes
, vol.57
, pp. 1683-1692
-
-
Peng, F.1
Wu, D.2
Gao, B.3
-
27
-
-
5444272878
-
NF-κB activation and overexpression of regulated genes in human diabetic nephropathy
-
DOI 10.1093/ndt/gfh207
-
S Mezzano C Aros A Droguett, et al. 2004 NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy Nephrol Dial Transplant 19 2505 2512 10.1093/ndt/gfh207 10.1093/ndt/gfh207 15280531 1:CAS:528:DC%2BD2cXnvVOlt7k%3D (Pubitemid 39360096)
-
(2004)
Nephrology Dialysis Transplantation
, vol.19
, Issue.10
, pp. 2505-2512
-
-
Mezzano, S.1
Aros, C.2
Droguett, A.3
Burgos, M.E.4
Ardiles, L.5
Flores, C.6
Schneider, H.7
Ruiz-Ortega, M.8
Egido, J.9
-
28
-
-
66149137665
-
Experimental models for nephropathy
-
10.1177/1470320308098343 10.1177/1470320308098343 19126658 1:CAS:528:DC%2BD1MXovV2ntbo%3D
-
P Balakumar VA Chakkarwar V Kumar, et al. 2008 Experimental models for nephropathy J Renin Angiotensin Aldosterone Syst 9 189 195 10.1177/ 1470320308098343 10.1177/1470320308098343 19126658 1:CAS:528: DC%2BD1MXovV2ntbo%3D
-
(2008)
J Renin Angiotensin Aldosterone Syst
, vol.9
, pp. 189-195
-
-
Balakumar, P.1
Chakkarwar, V.A.2
Kumar, V.3
-
29
-
-
58049134293
-
Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in rats
-
10.1007/s11010-008-9917-z 10.1007/s11010-008-9917-z 18830571 1:CAS:528:DC%2BD1cXhsVOntLnN
-
P Balakumar VA Chakkarwar M Singh 2009 Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in rats Mol Cell Biochem 320 149 162 10.1007/s11010-008-9917-z 10.1007/s11010-008-9917-z 18830571 1:CAS:528:DC%2BD1cXhsVOntLnN
-
(2009)
Mol Cell Biochem
, vol.320
, pp. 149-162
-
-
Balakumar, P.1
Chakkarwar, V.A.2
Singh, M.3
-
30
-
-
67349188030
-
Emerging role of PPAR ligands in the management of diabetic nephropathy
-
doi: 10.1016/j.phrs.2009.01.010
-
Balakumar P, Arora MK, Singh M (2009) Emerging role of PPAR ligands in the management of diabetic nephropathy. Pharmacol Res. doi: 10.1016/j.phrs.2009. 01.010
-
(2009)
Pharmacol Res.
-
-
Balakumar, P.1
Arora, M.K.2
Singh, M.3
-
31
-
-
0141484392
-
Paul Ehrlich's doctoral thesis: A milestone in the study of mast cells
-
DOI 10.1046/j.1365-2141.2003.04573.x
-
E Crivellato C Beltrami F Mallardi, et al. 2003 Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells Br J Haematol 123 19 21 10.1046/j.1365-2141.2003.04573.x 14510938 (Pubitemid 37222753)
-
(2003)
British Journal of Haematology
, vol.123
, Issue.1
, pp. 19-21
-
-
Crivellato, E.1
Beltrami, C.A.2
Mallardi, F.3
Ribatti, D.4
-
32
-
-
0031784389
-
Tubulointerstitial mast cell infiltration in glomerulonephritis
-
10.1016/S0272-6386(98)70022-8 10.1016/S0272-6386(98)70022-8 9774120 1:STN:280:DyaK1cvksFWjtg%3D%3D
-
K Hiromura M Kurosawa S Yano, et al. 1998 Tubulointerstitial mast cell infiltration in glomerulonephritis Am J Kidney Dis 32 593 599 10.1016/S0272-6386(98)70022-8 10.1016/S0272-6386(98)70022-8 9774120 1:STN:280:DyaK1cvksFWjtg%3D%3D
-
(1998)
Am J Kidney Dis
, vol.32
, pp. 593-599
-
-
Hiromura, K.1
Kurosawa, M.2
Yano, S.3
-
33
-
-
0037323482
-
4IgE, mast cells, basophils, and eosinophils
-
10.1067/mai.2003.120 10.1067/mai.2003.120 12592295 1:CAS:528: DC%2BD3sXisleiur8%3D
-
C Prussin DD Metcalfe 2003 4IgE, mast cells, basophils, and eosinophils J Allergy Clin Immunol 111 S486 S494 10.1067/mai.2003.120 10.1067/mai.2003.120 12592295 1:CAS:528:DC%2BD3sXisleiur8%3D
-
(2003)
J Allergy Clin Immunol
, vol.111
-
-
Prussin, C.1
Metcalfe, D.D.2
-
34
-
-
0029763947
-
Mast cells and type VIII collagen in human diabetic nephropathy
-
10.1007/BF02658509 10.1007/BF02658509 8897010 1:STN:280: DyaK2s%2Flt1ektA%3D%3D
-
BM Ruger Q Hasan NS Greenhill, et al. 1996 Mast cells and type VIII collagen in human diabetic nephropathy Diabetologia 39 1215 1222 10.1007/BF02658509 10.1007/BF02658509 8897010 1:STN:280:DyaK2s%2Flt1ektA%3D%3D
-
(1996)
Diabetologia
, vol.39
, pp. 1215-1222
-
-
Ruger, B.M.1
Hasan, Q.2
Greenhill, N.S.3
-
36
-
-
33646898812
-
Mast cell biology in evolution
-
DOI 10.1016/j.jaci.2006.03.031, PII S0091674906007378
-
DD Metcalfe JA Boyce 2006 Mast cell biology in evolution J Allergy Clin Immunol 117 1227 1229 10.1016/j.jaci.2006.03.031 10.1016/j.jaci.2006.03.031 16750978 1:CAS:528:DC%2BD28XlsVaqt70%3D (Pubitemid 43795745)
-
(2006)
Journal of Allergy and Clinical Immunology
, vol.117
, Issue.6
, pp. 1227-1229
-
-
Metcalfe, D.D.1
Boyce, J.A.2
-
37
-
-
51649115383
-
Mast cells and mastocytosis
-
10.1182/blood-2007-11-078097 10.1182/blood-2007-11-078097 18684881 1:CAS:528:DC%2BD1cXpvVOks7g%3D
-
DD Metcalfe 2008 Mast cells and mastocytosis Blood 112 946 956 10.1182/blood-2007-11-078097 10.1182/blood-2007-11-078097 18684881 1:CAS:528:DC%2BD1cXpvVOks7g%3D
-
(2008)
Blood
, vol.112
, pp. 946-956
-
-
Metcalfe, D.D.1
-
38
-
-
0344780197
-
Mast cells in rapidly progressive glomerulonephritis
-
1:STN:280:DyaK1Mzjt1WitA%3D%3D
-
T Toth R Toth-Jakatics S Jimi, et al. 1999 Mast cells in rapidly progressive glomerulonephritis Am Soc Nephrol 10 1498 1505 1:STN:280: DyaK1Mzjt1WitA%3D%3D
-
(1999)
Am Soc Nephrol
, vol.10
, pp. 1498-1505
-
-
Toth, T.1
Toth-Jakatics, R.2
Jimi, S.3
-
39
-
-
57049121785
-
Increased mast cell number in human hypertensive nephropathy
-
10.1152/ajprenal.00374.2007 10.1152/ajprenal.00374.2007 18684889 1:CAS:528:DC%2BD1cXht1ymu77J
-
P Welker S Kramer DA Groneberg, et al. 2008 Increased mast cell number in human hypertensive nephropathy Am J Physiol Renal Physiol 295 F1103 F1109 10.1152/ajprenal.00374.2007 10.1152/ajprenal.00374.2007 18684889 1:CAS:528:DC%2BD1cXht1ymu77J
-
(2008)
Am J Physiol Renal Physiol
, vol.295
-
-
Welker, P.1
Kramer, S.2
Groneberg, D.A.3
-
40
-
-
0036085728
-
Mast cells and angiogenesis: Review article
-
DOI 10.1034/j.1600-0463.2002.100501.x
-
K Norrby 2002 Mast cells and angiogenesis APMIS 110 355 371 10.1034/j.1600-0463.2002.100501.x 10.1034/j.1600-0463.2002.100501.x 12076253 1:CAS:528:DC%2BD38Xls1eisrw%3D (Pubitemid 34666551)
-
(2002)
APMIS
, vol.110
, Issue.5
, pp. 355-371
-
-
Norrby, K.1
-
41
-
-
58049213898
-
The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile
-
10.1093/intimm/dxn128 10.1093/intimm/dxn128 19073880 1:CAS:528: DC%2BD1cXhsFagu7rP
-
MK Andersson M Enoksson M Gallwitz, et al. 2009 The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile Int Immunol 21 95 104 10.1093/intimm/dxn128 10.1093/intimm/dxn128 19073880 1:CAS:528: DC%2BD1cXhsFagu7rP
-
(2009)
Int Immunol
, vol.21
, pp. 95-104
-
-
Andersson, M.K.1
Enoksson, M.2
Gallwitz, M.3
-
42
-
-
0023262466
-
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
-
3295549 1:STN:280:DyaL2s3ivVyqtQ%3D%3D
-
LB Schwartz DD Metcalfe JS Miller, et al. 1987 Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis N Engl J Med 316 1622 1626 3295549 1:STN:280:DyaL2s3ivVyqtQ%3D%3D
-
(1987)
N Engl J Med
, vol.316
, pp. 1622-1626
-
-
Schwartz, L.B.1
Metcalfe, D.D.2
Miller, J.S.3
-
43
-
-
0036034288
-
Heterotypic adhesion-induced mast cell activation: Biologic relevance in the inflammatory context
-
DOI 10.1016/S0161-5890(02)00089-5, PII S0161589002000895
-
YA Mekori D Baram 2002 Heterotypic adhesion-induced mast cell activation: biologic relevance in the inflammatory context Mol Immunol 38 1363 1367 10.1016/S0161-5890(02)00089-5 10.1016/S0161-5890(02)00089-5 12217409 1:CAS:528:DC%2BD38Xms1alu7s%3D (Pubitemid 35253778)
-
(2002)
Molecular Immunology
, vol.38
, Issue.16-18
, pp. 1363-1367
-
-
Mekori, Y.A.1
Baram, D.2
-
44
-
-
67349117682
-
Recent advances in pharmacotherapy for diabetic nephropathy: Current perspectives and future directions
-
doi: 10.1016/j.phrs.2009.02.002
-
Balakumar P, Arora MK, Ganti SS, et al. (2009) Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions. Pharmacol Res. doi: 10.1016/j.phrs.2009.02.002
-
(2009)
Pharmacol Res.
-
-
Balakumar, P.1
Arora, M.K.2
Ganti, S.S.3
-
45
-
-
0031053824
-
Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes
-
10.2337/diabetes.46.3.473 10.2337/diabetes.46.3.473 9032105 1:CAS:528:DyaK2sXhsVKjt70%3D
-
IS Park H Kiyomoto SL Abboud, et al. 1997 Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes Diabetes 46 473 480 10.2337/diabetes.46.3.473 10.2337/diabetes.46.3.473 9032105 1:CAS:528:DyaK2sXhsVKjt70%3D
-
(1997)
Diabetes
, vol.46
, pp. 473-480
-
-
Park, I.S.1
Kiyomoto, H.2
Abboud, S.L.3
-
46
-
-
0027375770
-
Transforming growth factor-beta 1 enhances glomerular collagen synthesis in diabetic rats
-
10.2337/diabetes.42.11.1673 10.2337/diabetes.42.11.1673 8405711 1:CAS:528:DyaK3sXms1enurw%3D
-
JS Bollineni AS Reddi 1993 Transforming growth factor-beta 1 enhances glomerular collagen synthesis in diabetic rats Diabetes 42 1673 1677 10.2337/diabetes.42.11.1673 10.2337/diabetes.42.11.1673 8405711 1:CAS:528:DyaK3sXms1enurw%3D
-
(1993)
Diabetes
, vol.42
, pp. 1673-1677
-
-
Bollineni, J.S.1
Reddi, A.S.2
-
47
-
-
0031775649
-
Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy
-
10.1159/000013415 10.1159/000013415 9845822 1:STN:280: DyaK1M%2FmtlKhsA%3D%3D
-
H Sato M Iwano Y Akai, et al. 1998 Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy Am J Nephrol 18 490 494 10.1159/000013415 10.1159/000013415 9845822 1:STN:280:DyaK1M%2FmtlKhsA%3D%3D
-
(1998)
Am J Nephrol
, vol.18
, pp. 490-494
-
-
Sato, H.1
Iwano, M.2
Akai, Y.3
-
48
-
-
0030975645
-
TGF-beta in kidney fibrosis: A target for gene therapy
-
10.1038/ki.1997.190 10.1038/ki.1997.190 9150449 1:CAS:528: DyaK2sXjsFShtrg%3D
-
WA Border NA Noble 1997 TGF-beta in kidney fibrosis: a target for gene therapy Kidney Int 51 1388 1396 10.1038/ki.1997.190 10.1038/ki.1997.190 9150449 1:CAS:528:DyaK2sXjsFShtrg%3D
-
(1997)
Kidney Int
, vol.51
, pp. 1388-1396
-
-
Border, W.A.1
Noble, N.A.2
-
49
-
-
0031656012
-
Evidence that TGF-β should be a therapeutic target in diabetic nephropathy
-
DOI 10.1046/j.1523-1755.1998.00127.x
-
WA Border NA Noble 1998 Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy Kidney Int 54 1390 1391 10.1046/j.1523-1755.1998. 00127.x 10.1046/j.1523-1755.1998.00127.x 9773681 1:STN:280:DyaK1cvksVKltg%3D%3D (Pubitemid 28449932)
-
(1998)
Kidney International
, vol.54
, Issue.4
, pp. 1390-1391
-
-
Border, W.A.1
Noble, N.A.2
-
50
-
-
0035230374
-
TGF-β: A crucial component of the pathogenesis of diabetic nephropathy
-
11413780 1:STN:280:DC%2BD38%2FhtlWlsA%3D%3D
-
S Goldfarb FN Ziyadeh 2001 TGF-β: a crucial component of the pathogenesis of diabetic nephropathy Trans Am Clin Climatol Assoc 112 27 32 11413780 1:STN:280:DC%2BD38%2FhtlWlsA%3D%3D
-
(2001)
Trans Am Clin Climatol Assoc
, vol.112
, pp. 27-32
-
-
Goldfarb, S.1
Ziyadeh, F.N.2
-
51
-
-
33845365039
-
Beneficial effect of TGFβ antagonism in treating diabetic nephropathy depends on when treatment is started
-
DOI 10.1159/000094967
-
A Benigni C Zoja M Campana, et al. 2006 Beneficial effect of TGF-beta antagonism in treating diabetic nephropathy depends on when treatment is started Nephron Exp Nephrol 104 e158 e168 10.1159/000094967 10.1159/000094967 16902320 1:CAS:528:DC%2BD28Xht1Gitr3I (Pubitemid 44885063)
-
(2006)
Nephron - Experimental Nephrology
, vol.104
, Issue.4
-
-
Benigni, A.1
Zoja, C.2
Campana, M.3
Corna, D.4
Sangalli, F.5
Rottoli, D.6
Gagliardini, E.7
Conti, S.8
Ledbetter, S.9
Remuzzi, G.10
-
52
-
-
33847011714
-
Evidence for a role of transforming growth factor (TGF)-β1 in the induction of postglomerular albuminuria in diabetic nephropathy: Amelioration by soluble TGF-β type II receptor
-
DOI 10.2337/db06-1018
-
LM Russo ED Re D Brown, et al. 2007 Evidence for a role of transforming growth factor (TGF)-β1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-β type II receptor Diabetes 56 380 388 10.2337/db06-1018 10.2337/db06-1018 17259382 1:CAS:528:DC%2BD2sXhs1ajsLo%3D (Pubitemid 46263076)
-
(2007)
Diabetes
, vol.56
, Issue.2
, pp. 380-388
-
-
Russo, L.M.1
Del Re, E.2
Brown, D.3
Lin, H.Y.4
-
53
-
-
34347350179
-
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells
-
DOI 10.1038/sj.ki.5002243, PII 5002243
-
1 expression is regulated by a mitogen-activated protein kinase in mesangial cells Kidney Int 72 45 52 10.1038/sj.ki.5002243 10.1038/sj.ki.5002243 17396111 1:CAS:528:DC%2BD2sXntVCjtL0%3D (Pubitemid 47014443)
-
(2007)
Kidney International
, vol.72
, Issue.1
, pp. 45-52
-
-
Huang, Y.1
Noble, N.A.2
Zhang, J.3
Xu, C.4
Border, W.A.5
-
54
-
-
0037530536
-
Chymase: A potential culprit in diabetic nephropathy?
-
DOI 10.1097/01.ASN.0000076125.12092.C6
-
E Ritz 2003 Chymase: a potential culprit in diabetic nephropathy? J Am Soc Nephrol 14 1952 1954 10.1097/01.ASN.0000076125.12092.C6 10.1097/01.ASN. 0000076125.12092.C6 12819257 (Pubitemid 36750492)
-
(2003)
Journal of the American Society of Nephrology
, vol.14
, Issue.7
, pp. 1952-1954
-
-
Ritz, E.1
-
55
-
-
18844452371
-
Cardiac chymase: Pathophysiological role and therapeutic potential of chymase inhibitors
-
DOI 10.1139/y04-136
-
SA Dogrell JC Wanstall 2005 Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors Can J Physiol Pharmacol 83 123 130 10.1139/y04-136 10.1139/y04-136 (Pubitemid 40695386)
-
(2005)
Canadian Journal of Physiology and Pharmacology
, vol.83
, Issue.2
, pp. 123-130
-
-
Doggrell, S.A.1
Wanstall, J.C.2
-
56
-
-
33645746010
-
Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications
-
DOI 10.1161/CIRCULATIONAHA.105.575589, PII 0000301720060314000013
-
V Koka W Wang XR Huang, et al. 2006 Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications Circulation 113 1353 1360 10.1161/CIRCULATIONAHA.105.575589 10.1161/CIRCULATIONAHA.105.575589 16520412 1:CAS:528:DC%2BD28XitVGntL0%3D (Pubitemid 43739457)
-
(2006)
Circulation
, vol.113
, Issue.10
, pp. 1353-1360
-
-
Koka, V.1
Wang, W.2
Xiao, R.H.3
Shokei, K.-M.4
Truong, L.D.5
Lan, H.Y.6
-
57
-
-
38749131190
-
Role of chymase-dependent matrix metalloproteinase-9 activation in mice with dextran sodium sulfate-induced colitis
-
DOI 10.1124/jpet.107.131946
-
K Ishida S Takai M Murano, et al. 2008 Role of chymase-dependent matrix metalloproteinase-9 activation in mice with dextran sodium sulfate-induced colitis J Pharmacol Exp Ther 324 422 426 10.1124/jpet.107.131946 10.1124/jpet.107.131946 18024785 1:CAS:528:DC%2BD1cXhsFShtr8%3D (Pubitemid 351185847)
-
(2008)
Journal of Pharmacology and Experimental Therapeutics
, vol.324
, Issue.2
, pp. 422-426
-
-
Ishida, K.1
Takai, S.2
Murano, M.3
Nishikawa, T.4
Inoue, T.5
Murano, N.6
Inoue, N.7
Jin, D.8
Umegaki, E.9
Higuchi, K.10
Miyazaki, M.11
-
58
-
-
0024547878
-
Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis
-
10.1172/JCI114051 10.1172/JCI114051 2468689 1:CAS:528:DyaL1MXit12qtrk%3D
-
LB Schwartz JW Yunginger J Miller, et al. 1989 Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis J Clin Invest 83 1551 1555 10.1172/JCI114051 10.1172/JCI114051 2468689 1:CAS:528:DyaL1MXit12qtrk%3D
-
(1989)
J Clin Invest
, vol.83
, pp. 1551-1555
-
-
Schwartz, L.B.1
Yunginger, J.W.2
Miller, J.3
-
59
-
-
38649123419
-
Tryptase enhances release of vascular endothelial growth factor from human osteoarthritic chondrocytes
-
18173920 1:STN:280:DC%2BD1c%2FgvVehsQ%3D%3D
-
K Masuko M Murata Y Xiang 2007 Tryptase enhances release of vascular endothelial growth factor from human osteoarthritic chondrocytes Clin Exp Rheumatol 25 860 865 18173920 1:STN:280:DC%2BD1c%2FgvVehsQ%3D%3D
-
(2007)
Clin Exp Rheumatol
, vol.25
, pp. 860-865
-
-
Masuko, K.1
Murata, M.2
Xiang, Y.3
-
60
-
-
0034924896
-
Role of mast cell tryptase in renal interstitial fibrosis
-
11461939 1:CAS:528:DC%2BD3MXlvVCku70%3D
-
S Kondo S Kagami H Kido, et al. 2001 Role of mast cell tryptase in renal interstitial fibrosis J Am Soc Nephrol 12 1668 1676 11461939 1:CAS:528:DC%2BD3MXlvVCku70%3D
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1668-1676
-
-
Kondo, S.1
Kagami, S.2
Kido, H.3
-
61
-
-
0032802747
-
Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy
-
DOI 10.1093/ndt/14.8.1904
-
J Dienum L Tarnow JM van Gool, et al. 1999 Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy Nephrol Dial Transplant 14 1904 1911 10.1093/ndt/14.8.1904 10.1093/ndt/14.8.1904 (Pubitemid 29358886)
-
(1999)
Nephrology Dialysis Transplantation
, vol.14
, Issue.8
, pp. 1904-1911
-
-
Deinum, J.1
Tarnow, L.2
Van Gool, J.M.3
De Bruin, R.A.4
Derkx, F.H.M.5
Schalekamp, M.A.D.H.6
Parving, H.-H.7
-
62
-
-
34347350179
-
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells
-
DOI 10.1038/sj.ki.5002243, PII 5002243
-
1 expression is regulated by a mitogen-activated protein kinase in mesangial cells Kidney Int 72 45 52 10.1038/sj.ki.5002243 10.1038/sj.ki.5002243 17396111 1:CAS:528:DC%2BD2sXntVCjtL0%3D (Pubitemid 47014443)
-
(2007)
Kidney International
, vol.72
, Issue.1
, pp. 45-52
-
-
Huang, Y.1
Noble, N.A.2
Zhang, J.3
Xu, C.4
Border, W.A.5
-
63
-
-
34848907212
-
Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats
-
DOI 10.1007/s00125-007-0795-9
-
DJ Kelly Y Zhang G Moe, et al. 2007 Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats Diabetologia 50 2398 2404 10.1007/s00125-007-0795-9 10.1007/s00125-007-0795-9 17828524 1:CAS:528:DC%2BD2sXhtFSlsL%2FI (Pubitemid 47512400)
-
(2007)
Diabetologia
, vol.50
, Issue.11
, pp. 2398-2404
-
-
Kelly, D.J.1
Zhang, Y.2
Moe, G.3
Naik, G.4
Gilbert, R.E.5
-
64
-
-
0019965561
-
Histamine stimulates renin release from the isolated perfused rat kidney
-
DOI 10.1007/BF00495872
-
U Schwertschlag E Hackenthal 1982 Histamine stimulates renin release from the isolated perfused rat kidney Naunyn Schmiedebergs Arch Pharmacol 319 239 242 10.1007/BF00495872 10.1007/BF00495872 6125902 1:CAS:528:DyaL38XlvFelsbo%3D (Pubitemid 12091320)
-
(1982)
Naunyn-Schmiedeberg's Archives of Pharmacology
, vol.319
, Issue.3
, pp. 239-242
-
-
Schwertschlag, U.1
Hackenthal, E.2
-
65
-
-
33751352908
-
Anti-tumour necrosis factor-α therapy in heart failure: Future directions
-
DOI 10.1111/j.1742-7843.2006.pto-508.x
-
P Balakumar M Singh 2006 Anti tumor necrosis factor-α therapy in heart failure: future direction Basic Clin Pharmacol Toxicol 99 391 397 10.1111/j.1742-7843.2006.pto-508.x 10.1111/j.1742-7843.2006.pto-508.x 17169118 1:CAS:528:DC%2BD2sXhs1Wjuw%3D%3D (Pubitemid 44813905)
-
(2006)
Basic and Clinical Pharmacology and Toxicology
, vol.99
, Issue.6
, pp. 391-397
-
-
Balakumar, P.1
Singh, M.2
-
66
-
-
0027394256
-
MRNA expression of growth factors in glomeruli from diabetic rats
-
T Nakamura M Fukui I Ebihara, et al. 1993 mRNA expression of growth factors in glomeruli from diabetic rats Diabetes 42 450 456 10.2337/diabetes.42. 3.450 10.2337/diabetes.42.3.450 8094359 1:CAS:528:DyaK3sXksVKksro%3D (Pubitemid 23066522)
-
(1993)
Diabetes
, vol.42
, Issue.3
, pp. 450-456
-
-
Nakamura, T.1
Fukui, M.2
Ebihara, I.3
Osada, S.4
Nagaoka, I.5
Tomino, Y.6
Koide, H.7
-
67
-
-
15844384068
-
Increased serum levels of interleukin-18 in patients with diabetic nephropathy
-
15646011
-
RA Mahmoud SA el-Ezz AS Hegazy 2004 Increased serum levels of interleukin-18 in patients with diabetic nephropathy Ital J Biochem 53 73 81 15646011
-
(2004)
Ital J Biochem
, vol.53
, pp. 73-81
-
-
Mahmoud, R.A.1
El-Ezz, S.A.2
Hegazy, A.S.3
-
68
-
-
0038386476
-
Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus
-
DOI 10.1016/S0272-6386(03)00408-6
-
JF Navarro C Mora M Macia, et al. 2003 Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus Am J Kidney Dis 42 53 61 10.1016/S0272-6386(03)00408-6 10.1016/S0272-6386(03)00408-6 12830456 1:CAS:528:DC%2BD3sXmtVajt7c%3D (Pubitemid 36807654)
-
(2003)
American Journal of Kidney Diseases
, vol.42
, pp. 53-61
-
-
Navarro, J.F.1
Mora, C.2
Macia, M.3
Garcia, J.4
-
69
-
-
0037213986
-
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes
-
12388406 1:CAS:528:DC%2BD3sXmvF2luw%3D%3D
-
K Dipetrillo B Coutermarsh FA Gesek 2003 Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes Am J Physiol Renal Physiol 284 F113 F121 12388406 1:CAS:528:DC%2BD3sXmvF2luw%3D%3D
-
(2003)
Am J Physiol Renal Physiol
, vol.284
-
-
Dipetrillo, K.1
Coutermarsh, B.2
Gesek, F.A.3
-
70
-
-
0141674965
-
Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats
-
DOI 10.1046/j.1523-1755.2003.00237.x
-
K Kalantarinia AS Awad HM Siragy 2003 Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats Kidney Int 64 1208 1213 10.1046/j.1523-1755.2003.00237.x 10.1046/j.1523-1755.2003.00237.x 12969138 1:CAS:528:DC%2BD3sXotFyrtb8%3D (Pubitemid 37153785)
-
(2003)
Kidney International
, vol.64
, Issue.4
, pp. 1208-1213
-
-
Kalantarinia, K.1
Awad, A.S.2
Siragy, H.M.3
-
71
-
-
36248953302
-
Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats
-
DOI 10.1007/s00592-007-0007-6
-
Y Moriwaki T Inokuchi A Yamamoto, et al. 2007 Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats Acta Diabetol 44 215 218 10.1007/s00592-007-0007-6 10.1007/s00592-007-0007-6 17767370 1:CAS:528:DC%2BD2sXhtlSmu73F (Pubitemid 350132266)
-
(2007)
Acta Diabetologica
, vol.44
, Issue.4
, pp. 215-218
-
-
Moriwaki, Y.1
Inokuchi, T.2
Yamamoto, A.3
Ka, T.4
Tsutsumi, Z.5
Takahashi, S.6
Yamamoto, T.7
-
72
-
-
0028844376
-
Inhibition of tumour necrosis factor-alpha (TNF-α) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium
-
7554404 1:CAS:528:DyaK2MXpsFGnt7g%3D
-
EY Bissonnette JA Enciso AD Befus 1995 Inhibition of tumour necrosis factor-alpha (TNF-α) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium Clin Exp Immunol 102 78 84 7554404 1:CAS:528:DyaK2MXpsFGnt7g%3D
-
(1995)
Clin Exp Immunol
, vol.102
, pp. 78-84
-
-
Bissonnette, E.Y.1
Enciso, J.A.2
Befus, A.D.3
-
73
-
-
57149091790
-
Role of mast cells in progressive renal diseases
-
10.1681/ASN.2008010015 10.1681/ASN.2008010015 1:CAS:528: DC%2BD1MXlvF2hsQ%3D%3D
-
SR Holdworth SA Summers 2008 Role of mast cells in progressive renal diseases J Am Soc Nephrol 19 2254 2261 10.1681/ASN.2008010015 10.1681/ASN.2008010015 1:CAS:528:DC%2BD1MXlvF2hsQ%3D%3D
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 2254-2261
-
-
Holdworth, S.R.1
Summers, S.A.2
|